Trivarx Ltd has released a press release.
Preliminary Final Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Departure of Managing Director & Chief Executive Officer
- Medibio Submits FDA De Novo Application
- Medibio Receives TGA Approval
- MEB Signs Global Contract with Jacobs Engineering
- Medibio Announces Next Tranche of Corporate Health Contracts
Later from TrivarX
- Clinical Study Shows Improvement to Diagnostic Standard
- Executive Leadership Changes
- Notice Received Under Section 249D of the Corporations Act
- Medibio Releases Corporate Health Product, ilumen
- Receipt of R&D Tax Incentive Refund
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX